In the genomic era, group association tests are of great interest. Due to the overwhelming number of individual genomic features, the power of testing for association of a single genomic feature at a time is often very small, as are the effect sizes for most features. Many methods have been proposed to test association of a trait with a group of features within a functional unit as a whole, e.g. all SNPs in a gene, yet few of these methods account for the fact that generally a substantial proportion of the features are not associated with the trait. In this paper, we propose to model the association for each feature in the group as a mixture of features with no association and features with non-zero associations to explicitly account for the possibility that a fraction of features may not be associated with the trait while other features in the group are. The feature-level associations are first estimated by generalized linear models; the sequence of these estimated associations is then modeled by a hidden Markov chain. To test for global association, we develop a modified likelihood ratio test based on a log-likelihood function that ignores higher order dependency plus a penalty term. We derive the asymptotic distribution of the likelihood ratio test under the null hypothesis. Furthermore, we obtain the posterior probability of association for each feature, which provides evidence of feature-level association and is useful for potential follow-up studies. In simulations and data application, we show that our proposed method performs well when compared with existing group association tests especially when there are only few features associated with the outcome.
INTRODUCTION
With the fast growth in high-throughput sequencing technologies, identifying important features that are associated with a disease trait in a genome-wide study has become possible. Notable examples include rare variant association in human genome sequencing studies (Morgenthaler and Thilly, 2007; Morris and Pan, 2010; Wu and others, 2009) , and sieve analyses in HIV vaccine trials comparing viral sequences between vaccines and placebo recipients (Rolland and others, 2012) . Due to the overwhelming burden of multiple testing, testing for association between disease and individual features often lack power. To aggregate individual weak associations and reduce the number of tests, numerous methods have been proposed to perform a global association test within a functional unit, e.g. a gene or a pathway. Motivated by, though certainly not limited to, rare-variant association testing, we propose in this paper a novel group association test named "hidden Markov model variable detection method" (HMVD).
C log( p) term to the log-likelihood function, so the support of p is limited to (0, 1] . Correlated Z statistics are modelled by a hidden Markov chain, so that the proportion of null features and posterior probabilities can be computed by a extension of the Baum-Welsh algorithm. For hypothesis testing, we propose a modified likelihood ratio test ignoring the higher order correlation between features with the aforementioned penalty term. We show that the asymptotic distribution under the null hypothesis follows a χ 2 1 distribution. Another contribution of our method is its "model selection" feature. On top of its ability to test for overall association, HMVD also provides a posterior probability for each feature, summarizing how likely it is marginally associated with the outcome. This property is desirable since it allows one to identify important features amongst a pool of candidate features, thereby providing guidance for follow-up studies.
METHODS
In this paper, we focus on testing whether a set of m predictors (or features) (G) is related to an outcome variable Y while being adjusted for extra confounding variables (covariates) X. For n independent subjects, let Y be an n × 1 vector, X be an n × q matrix, and let G be an n × m matrix. We assume that our samples are obtained either from a case-control study or a cohort study; Y can be either a dichotomized disease variable or a continuous response. The traditional way to test association of a group of features is to fit a multiple regression model, g{E(Y )} = Xβ + Gθ, where β is the coefficient for X, θ is the coefficient for G. The usual F/χ 2 statistic to test θ = 0 will have limited power when m is large. Rather than fitting one model for all m features, which can be cumbersome when m is large, we fit a separate model for each feature:
where G k is the kth column of G. For the kth feature, the estimated associationθ k and its estimated variancê σ 2 k can be obtained through model (2.1). We assume that within a set of features, only some of these features are associated with the outcome. Let W k , k = 1, . . . , m, be an indicator whether feature k is associated with the outcome, and assume all associated features share the same effect size θ , we havê
Note that without any rescaling of the features, σ 2 k → 0 as n increases. The assumption that all associated features have the same effect size may seem restrictive. However, we note that in many applications where all features are jointly tested these features are "similar", e.g. they are all sequence variants within the same gene that may disrupt the function of that gene in a similar manner. As such, we believe that this assumption can be a reasonable approximation. We note that it is also possible to a priori rescale some of the features G k , for example to give them the same variance, or to incorporate some prior believes about effect sizes. In our simulation study, we will see that our method maintains correct control of the type I error and has good power, even if the assumption of the same effect size is not satisfied.
Our testing procedure has two parts: the "generic" regression model that relates Y to G and X (2.1), and the HMM that relates the sequence of estimated association θ k (2.2). The goal here is to develop a test for association of a group of features using the second model. For this test to be valid, the actual form of (2.1) can be flexible: we require only an estimateθ k for k features and their estimated covariance matrix. We can also apply our procedure to a set of test statistics Z k , k = 1, . . . , m, specifying se(θ k ) = 1, for k = 1, . . . , m. Such "weighted version", can be obtained when each feature G k is divided by the (unweighted) se (θ k 
]. Denote the variance by ; its estimateˆ can be estimated from the data.
Hidden Markov model
To describe the likelihood of observed data, we need to impose some structure on the sequence of latent variables W k 's to use (2.2) for group testing. The simplest structure is to assume that the W k 's are independent, and that each follows a Bernoulli distribution with P(W k = 1) = p: that is, each feature has an equal "chance" of being associated with Y , independent of the other features. In this paper, we assume that the W k follow a stationary Markov chain with transition matrix A = (a st ), s, t = 0, 1, where a s0 + a s1 = 1 and a st = P(W k+1 = t|W k = s). We assume that the features can be ordered in a meaningful way, and that whether one feature is associated with the response may be informative on whether the next feature is associated with the response. For example, for genetic data, there is a natural order of variants along the chromosome. The Markovian structure implies that for neighboring SNPs, if one is associated with the outcome the other one is more likely to be associated with the outcome. We note that when a 00 = a 10 , the Markov chain model is equivalent to the simple Bernoulli model with p = a 01 . We define the emission probabilities, i.e. the conditional distribution of θ k given θ 1 , . . . , θ k−1 and the hidden states up to
When n is sufficiently large,ˆ is a multivariate Gaussian distribution given all the hidden states. We obtain the likelihood ofˆ by summing over all hidden states:
, where π w 1 = P(W 1 = w 1 ). Contrary to the usual first-order HMMs, the emission probability of a feature depends on the hidden states of the feature itself and all prior features. Therefore, the full likelihood ofθ 1 , . . . ,θ m involves summation over all possible combinations of the prior hidden states for each W k , which is computationally infeasible. Some simplification is needed. We consider two strategies for accounting for the dependency between features: for the hypothesis testing purpose, we develop a modified likelihood ratio test that ignores the higher order dependency and we prove that the resulting test is still valid. For estimating the posterior probability of an individual feature, we use a modified Baum-Welsh algorithm that reduced the dependency in emission probabilities to the first order only, thereby substantially reducing the burden of computation.
We formulate a model similar to the standard hidden Markov model (HMM) with one key difference. In the standard HMM, all observationsθ k are assumed to be conditionally independent, that is, it is assumed
These assumptions are usually not satisfied in our setting, since the effects from neighboring features (e.g. SNPs) are likely to be correlated. We generalize the HMM by allowing first-order conditional dependence between neighboring features and ignoring any higher order correlations.
In particular, we assume that
) and π w 1 = P(W 1 = w 1 ). Then the likelihood function, by ignoring higher order conditional correlations, can be expressed as
(2.3)
Hypothesis testing
The primary goal of this paper is group testing for association. Assume that the Markov chain W k is stationary, then p P(W = 1) = a 01 /(a 10 + a 01 ). Testing for association between outcome and features is equivalent to testing for the composite null hypothesis
This set-up has two complications. First, the parameters are not identifiable under H 0 ; when p = 0, θ vanishes in the likelihood, and when θ = 0, p vanishes. Second, there are no existing results about the distribution for the likelihood ratio test statistics under the HMM setting described here. To eliminate the identifiability problem, one approach is to add a small penalty term, that pushes one component of the null parameters away from its boundary value (e.g. Chen and others, 2001; Fu and others, 2009 ). In the HMM setting, tests based on the marginal distribution ofˆ , ignoring dependency, have been proposed (Dannemann and Holzmann, 2008) . The rational for this approximation is that the number of states in the HMM is equivalent to the number of components for eachθ k . Under H 0 , when the HMM only has one state, marginallyθ k follows a normal distribution with mean 0. Under the alternative, when the HMM has two states, marginallyθ k |θ k−1 follows a mixture of four normal distributions, with the mixture probabilities being p 00 = (1 − p)a 00 , p 01 = (1 − p)a 01 , p 10 = pa 10 , and p 11 = pa 11 .
In our method, η k θ k − B kθk−1 has a distribution that is a mixture of four normal distributions:
Here φ(x|μ, σ 2 ) denotes the normal probability density function evaluated with mean μ and variance σ 2 . Then the likelihood function forˆ , ignoring higher order dependency, is
We propose the following modified log-likelihood function:
and we construct a likelihood ratio test based on this expression. As discussed in Chen and others (2001) , the best choice of the tuning parameter C depends on the model. In our simulation study we find that the value of C affects both the type I error and the power: setting C too large will reduce the power while setting C too small will lead to some inflation of the type I error. We found that C = 1 yields a good balance between type I error and power. Interestingly, maximizing (2.6) will still give us a consistent estimator of θ . Related results on the consistency for MLEs while assuming independence have been discussed in Chandler and Bate (2007) and Zhou and others (2001) .
Note bothθ k and σ k|k−1 are of order n −1/2 , it is natural to make the following transformation and rewrite the log-likelihood function.
) and the modified log-likelihood function can be rewritten as
Now define the modified likelihood ratio test (MLRT) statistics as
where θ is the covariance matrix for
is the sum of all diagonal elements of θ and θ is the sum of all elements in θ . Then the following two theorems show the consistency of the estimator ofθ and the asymptotic distribution of R m under the null hypothesis. The proofs of the theorems are given in Supplementary material available at Biostatistics online. For data with limited sample size and small number of features, we observed small inflation of type I errors. We refer to the p-values that are obtained using Theorem 2.2 as approximate p-values. In cases where accurate p-values are needed, we propose the following adaptive permutation strategy. For each test, we obtain andˆ as described in Section 2 and the approximate p-value p 0 . Under the null hypothesis,ˆ follows a multivariate normal distribution with mean 0 and covarianceˆ , denoted by MVN(0,ˆ ). Given a significance level α, the adaptive permutation tests proceeds as follows. The first step is to determine whether a permutation test is needed. If p 0 is large enough compared with α, then there is no need to conduct a permutation test. In both the power comparison and type I error calculation in Section 3, we do not initiate the permutation test if p 0 > 5α. Otherwise, we set the number of permutations nperm
, where [a] is the greatest integer that is less than a and N > 1 is a user defined parameter. Throughout the paper, we set N to be 10. For permutation i, we generate i from MVN(0,ˆ ) and calculate the corresponding approximate p-value p i , i = 1, . . . , nperm. Then a test is claimed to be significant at level α
The proposed adaptive permutation procedure is similar to the method introduced in Besag and Clifford (1991) .
Estimation
Recall that the likelihood function based on the HMM structure, while ignoring higher order dependency, is
To deal with the composite null issue discussed in the previous section, we add a penalty term to the above likelihood function and Group association test using HMM 227 obtain the following penalized version:
We can estimate θ by maximizing expression (2.9). Maximization can be done using a modified BaumWelsh algorithm. A detailed description of this algorithm is given in Supplementary material available at Biostatistics online.
SIMULATION STUDY
In this section, we conduct simulation study to evaluate the performance of the proposed HMVD method in settings with continuous and binary features and in settings with continuous and binary outcomes.
Type I error control for finite sample
We perform HMVD tests under the null hypothesis and calculate type I error rates in various settings. For each setting, the empirical type I error rate is obtained based on independent simulated datasets. Sample sizes are n = 2000 and n = 4000. The outcome Y is generated either from a standard normal distribution or from a Bernoulli distribution with p = 0.5.
For continuous features, we generated 20 and 40 features with two different covariance matrix structures: independent features or features with an "AR1" correlation structure cor(G k , G k+d ) = 0.25 |d| . The marginal variance of each feature was one for all simulations.
For discrete features, we generate genetic data mimicking real SNP data. We use HAPGEN2 (Spencer and others, 2009 ) and the CEU sample from the Hapmap project (data release #24) to generate genotypes of the Von Willebrand Factor (VWF) gene on chromosome 12. To generate rare variants, we only select those variants with minor allele frequency (MAF) < 0.05. We select the first 20 or 40 variants to be consistent with the setting for continuous features.
For each simulation, we calculate the proportion of times the group of features is declared as significantly associated with the outcome at three thresholds (α = 0.01, 0.001, and 0.0001). For α = 0.01, we generated 10 5 simulated datasets and for α = 0.001 and α = 0.0001, we generated 10 6 simulated datasets to test for the type I error rates. Results for independent features and discrete features are given in Tables 1-2 . Overall, the type I error rates are well controlled. The p-values are conservative for small sample size when outcome is binary and features are generated based on VWF gene. This is due to the conservative standard error obtained using logistic regression for small sample size when MAFs are small. Results for features generated from "AR1" correlation structure are given in Supplementary material available at Biostatistics online. The type I error rates are also well controlled.
Power comparison
To study the power of our proposed approach, we compare HMVD with other popular group testing methods: SKAT (Wu and others, 2009) , SKAT-O (Lee and others, 2013) , VBDM (Logsdon and others, 2014) , SigmaP (Cheung and others, 2012) , and the Burden test (Morris and Pan, 2010) . We examine the power for the different methods across a variety of settings. The features that are associated with the response are selected independently with probability p = 0.1 (sparse signal) or 0.2 (denser signal). The number of features is again set to be either 20 or 40. Note that for m = 20 and p = 0.1 in ∼12% of the simulations there is no signal, so for this setting the maximum power is around 88%. The sample size is set to be 4000 
The effect sizes θ k are generated under two scenarios: In the first scenario, we assume that the features associated with the outcome share the same effect size, i.e., θ k = 0 or θ k = θ (when our model is correct); In the second scenario we assume that the associated features have different effect sizes, such that θ k = 0 or θ k ∼ θ × N (1, 2) . This scenario is used to study the robustness of HMVD against model misspecification. We note that in the second scenario on average 31% of the truly associated θ k will have effects that are in the opposite direction from the other θ k . Under each scenario, the associated features are chosen randomly and we report the percentages of tests that are significant at level α = 0.005 over 1000 runs.
We generate continuous features G k using the same covariance matrix structures as we used for the simulations for evaluating type I error. The effect size θ take the value 0.04, 0.08, 0.12, or 0.16. These effect sizes are chosen such that the resulting powers cover a reasonable range. Figure 1 shows the comparison for the independent covariance structure. The top 2 panels are for continuous outcomes. All associated features share the common effect in the first panel and have different effect sizes in the second panel. The bottom 2 panels are for binary outcomes with common and different effect sizes. Results for features generated from "AR1" correlation structure are given in Supplementary material available at Biostatistics online.
For ordinal features, we compare power based on data generated using the VWF gene, as described in previous subsection. The MAF spectrum for selected SNPs in VWF gene is given in Appendix of Supplementary material available at Biostatistics online. The effect size θ takes value 0.3, 0.6, 0.9, and 1.2. Results for ordinal features are given in Figure 2 with the same layout as Figure 1 .
The proposed method and VBDM yield the greatest power for the continuous outcome binary predictor case (Figure 2 ). For all other set ups, HMVD has the best power, even for settings with model misspecification. The setting with "m = 20, p = 0.2" and the setting with "m = 40, p = 0.1" provide equivalent numbers of truly associated predictors but with different numbers of noise features (predictors that are not associated with the outcome). The effect of more noise features can be observed by comparing column 2 and column 3 in each figure. Noise features have the strongest effect on the Burden test: the power is greatly reduced when the number of noise features increases. Noise features have some effect on all other methods, though the effect on HMVD is minimal in many cases, suggesting that HMVD has the ability to better discern signals from noise. As mentioned earlier, model misspecification does not affect the performance of the proposed method. Another interesting observation is that our method show substantial advantages when the features are generated independently. This is plausible since we first conduct a variable by variable regression for each feature. The correlation structure is not explicitly modeled in the likelihood ratio test. We observe a slightly smaller advantage when all features are correlated. This is 6.9 × 10 −4 0.60 < 1 × 10 −7 Weighted 0.58 1.6 × 10 −7 1.1 × 10 −6 < 1 × 10 −7 < 1 × 10 −6 expected since we are conducting tests based on estimated effects: when all features are positively correlated, the effective sample size is reduced, which affects the power.
DATA ANALYSIS
We apply our method to the same dataset from the Exome Sequencing Project (ESP) African American (AA) participants as studied in Logsdon and others (2014) and Johnsen and others (2013) Low levels of VWF are associated with higher risk of Von Willebrand disease (VWD), a type of bleeding disorder. Johnsen and others (2013) and Logsdon and others (2014) showed that VWF missense variants are associated with VWF levels within the AA population. The dataset consists of 2487 AA subjects from the CARe consortium who were imputed using the 1000-genomes reference panel as part of the ESP. Details of the imputation are in Auer and others (2012) . There are a total of 30 imputed missense VWF variants. Two pairs of the variants are highly correlated with correlation > 0.9; we remove one from each pair to reduce the collinearity and end up with 28 imputed missense VWF variants. We apply our method to study the association between 28 imputed missense VWF variants and log-transformed VWF level. In this section, we apply both weighted and unweighted version of our method for testing association. We obtain strong evidence of association with a χ 2 p-value of 9.1 × 10 −8 and 4.2 × 10 −9 and permutation based p-value < 10 −6 and < 10 −7 for the weighted and unweighted procedures, respectively. SKAT and SKAT-O also yield significant results, but the significance levels are not as strong as those for HMVD. For the VBDM method of Logsdon and others (2014) , the weighted version found a significant association; however, the unweighted version failed to establish association. In Table 3 , p-values using different methods are summarized for comparison. It should also be noted that all other methods seem to be sensitive to the choice of weights.
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Our method identifies four low-frequency variants that have a strong association with the outcome (with posterior probabilities >0.99) and all the other variants seems to contribute little to the association (with posterior probabilities close to 0); see Table 4 . Three of the four variants selected by HMVD are Arg2287Trp, Ser1486Leu, and Val1439Met, which concord perfectly with the results reported in Johnsen and others (2013) . Interestingly, in Johnsen and others's report, the effects of these three variants are of similar size, so it is not surprising that the unweighted version of our test establishes a significant effect (the weighted version provided similar results). The variants that show strong evidence of association are shown in bold.
DISCUSSION
In this paper, we propose HMVD, a general group association test. By introducing a hidden indicator variable, our method explicitly accounts for the fact that a portion of variables might not be associated with the outcome. Compared with other group association tests HMVD yields increased power in a variety of scenarios. Our method is especially powerful when only a small fraction of all candidate features are associated with the outcome. Under both the HMM framework and the marginal independent likelihood framework, we obtain a posterior probability for each predictor being associated with the outcome. These probabilities serve as evidence of association for follow-up studies. We establish asymptotic distribution results of the HMVD test statistics for any generalized linear model.
As is evident from our example, HMVD is not very sensitive to the choice of weighting scheme, while other methods may provide different conclusions based on the choices of weights. This property is desirable since the "true" weight is never known, and ideally choice of weights should not affect the conclusions.
There are several possible extensions of our approach. First, in this paper, we assume all the associated features to have effects in one direction. Extensions can be made to allow both features with positive association and features with negative association. Second, although we focus on group-wise association test, our framework can be easily extended to other settings such as the identification of gene-environment interaction, or group-wise testing when features have entirely different scales.
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